American Journal of Neuroradiology 27:919-921, April 2006
© 2006 American Society of Neuroradiology
Case Report
BRAIN
Xanthoma Disseminatum of the Central Nervous System and Cranium
I.T. Zaka,
D. Altinoka,
S.S.F. Neilsenb and
K.K. Kisha
a Department of Radiology, Wayne State University, Detroit, Mich
b Department of Radiology, Michigan State University, Lansing, Mich
Address correspondence to Imad T. Zak, MD, Department of Radiology, Harper University Hospital, 3990 John R, Detroit, MI 48201
 |
Abstract
|
|---|
SUMMARY: Xanthoma disseminatum is a rare normolipemic histiocytic
disorder of non-Langerhans cell origin. It is a chronic systemic
disease with a benign course, characterized by disseminated,
yellow-orange–colored papules on the face, flexures, and
mucosal membranes. We report 3 patients with xanthoma disseminatum,
who presented primarily with central nervous system disease
and a multitude of imaging findings throughout the craniospinal
axis.
|
Introduction
|
|---|
Xanthoma disseminatum affects different age populations, and
cases have been reported between the ages of 5 months and 70
years. The disease is more prevalent in males with a male-to-female
ratio of 2:1. No typical inheritance pattern or geographic distribution
is recognized.
1 Three clinical variants are described on the
basis of disease progression and prognosis: a common persistent
form, a less common progressive form with systemic involvement,
and a rare form of self-limited disease. Central nervous system
(CNS) involvement is rare and usually occurs in the systemic
variety.
2,3 Xanthoma disseminatum is characterized by a normal
lipid profile.
1,4 Diabetes insipidus is a common manifestation
of xanthoma disseminatum, related to extensive meningeal involvement
in the region of the sella and hypophysis.
5–9
|
Case 1
|
|---|
A 23-year-old white woman presented with partial complex seizure
in the left upper extremity. Initial work-up disclosed a normal
biochemical profile. A brain MR imaging examination on admission
showed a 3-cm round heterogeneously enhancing mass in the right
thalamus with a small amount of vasogenic edema and mild local
mass effect (
Fig 1). The patient underwent complete surgical
excision of the tumor. Histopathologic findings suggested the
histiocytic nature of the tumor, and additional histochemical
analysis confirmed a diagnosis of xanthoma disseminatum. Three
months later a follow-up MR imaging examination showed local
recurrence of the tumor. A second surgery was performed, and
the mass was partially removed. Radiation therapy was administered.
Twelve months later, the patient presented with progressive
weakness in the extremities and inability to stand upright.
MR imaging examination of the brain showed further progression
of the tumor with new lesions seen in the brain stem and proximal
spinal cord. MR imaging of the entire spine showed extensive
patchy T2 signal intensity abnormalities throughout the brain
stem and spinal cord. Postgadolinium images showed intensely
enhancing variable-sized intra- and extra-axial lesions (
Fig 2).
The patient died 2 years after initial presentation.
View larger version (71K):
[in this window]
[in a new window]
|
Fig 1. Case 1: A, Axial T1-weighted image shows a large heterogeneous mass lesion in the right thalamus with mild local mass effect.
B, Axial T2-weighted image shows a poorly defined heterogeneous mass with a small amount of vasogenic edema.
C, Axial T1-weighted image postgadolinium shows intense and heterogeneous enhancement of the mass lesion.
| |
View larger version (79K):
[in this window]
[in a new window]
|
Fig 2. Case 1. Sagittal T1-weighted image of the whole spine shows multiple intra- and extra-axial lesions with intense enhancement.
| |
|
Case 2
|
|---|
A 13-year-old black boy presented with chronic headache and
dizziness. The patient was otherwise healthy. Results of complete
blood counts and biochemical profiles were normal. Initial brain
MR imaging examination showed a large heterogeneous extra-axial
mass lesion with intense enhancement. There was considerable
mass effect on the cerebellum and fourth ventricle (
Fig 3).
The tumor was completely excised. Four years later, the patient
continues to do well with mild encephalomalacic changes in the
cerebellum and no evidence of tumor recurrence.
View larger version (82K):
[in this window]
[in a new window]
|
Fig 3. Case 2. A, Sagittal T1-weighted image shows a large heterogeneous extra-axial mass in the posterior fossa with central hemorrhage.
B, Sagittal T1-weighted image shows intense enhancement of the tumor. Notice the relationship of the tumor to the dura and the lack of a dural tail sign.
| |
|
Case 3
|
|---|
A 14-year-old white girl presented with a painless bump on her
head. There were no other complaints and no neurologic deficits.
Results of complete blood counts and biochemical profiles were
normal. A brain CT scan was initially performed and showed a
well-defined osteolytic lesion in the left parietal bone. A
brain MR imaging was subsequently performed and confirmed the
presence of an intensely enhancing calvarial tumor that had
violated the inner and outer tables (
Fig 4). A whole-body radionuclide
bone scan showed radiotracer uptake around the tumor in the
left parietal bone without additional abnormalities. Two years
later the patient remains free of disease.
View larger version (98K):
[in this window]
[in a new window]
|
Fig 4. Case 3. A, Axial T2-weighted image shows minimal vasogenic edema in the outer aspect of the adjacent parietal lobe.
B, Coronal T1-weighted image postgadolinium shows intense enhancement and a dural tail sign.
| |
|
Discussion
|
|---|
CNS involvement in histiocytic disorders is unusual and includes
forms of Langerhans cell histiocytosis, plasma cell granuloma,
Rosai-Dorfman disease, Erdheim-Chester disease, malignant fibrous
histiocytoma, histiocytic lymphoma, intracranial xanthoma associated
with hyperlipidemia, and xanthoma disseminatum. The distinction
between different histiocytic disorders became possible with
modern immunohistochemical techniques and electron microscopy.
1,4-6 Xanthoma disseminatum was described as a distinct histiocytic
disorder by Albrecht von Graefe in 1867. The disease is also
known as Montgomery syndrome and xanthoma multiplex.
4,6
Xanthoma disseminatum is characterized by large pleomorphic multinucleated histiocytes with foamy cytoplasm immunoreactive for CD68. The numerous histiocytes are intermixed with variable numbers of mature T-lymphocytes, immunoreactive for leukocyte common antigens and CD3. Atypia, mitoses, and necrosis are typically not present. No significant inflammatory component is seen (Fig 5). Histiocytic cells of xanthoma disseminatum are not immunoreactive for glial fibrillary acidic protein, which characterizes pleomorphic xanthoastrocytoma. Unlike other more common forms of histiocytosis, the histiocytic cells of xanthoma disseminatum are not immunoreactive for S-100. Birbeck granules, characteristic of Langerhans cell histiocytosis, are not seen on electron microscopy.1,4-6
View larger version (78K):
[in this window]
[in a new window]
|
Fig 5. Photomicrographs of a specimen from case 1 (Courtesy of William Kupsky, MD, Wayne State University, Detroit, Mich).
A, Hematoxylin and eosin stain (x400) shows numerous irregular large cells with abundant foamy cytoplasm and vesicular nuclei.
B, Xanthoma disseminatum cells stain (x400) strongly positive for the CD68 marker.
| |
MR imaging of the brain shows a well-defined heterogeneous and intensely enhancing intra-axial mass lesion. There is typically some local mass effect without significant vasogenic edema (case 1). A recently published case report described a patient with xanthoma disseminatum who presented with imaging features mimicking cerebral glioma.10 Extra-axial lesions are characterized by a well-circumscribed outline with intense enhancement and lack of the "dural tail" sign (case 2). Bony disease presented with sharply defined osteolytic and intensely enhancing geographic lesions, and bone scintigraphy showed mild radiotracer uptake (case 3). Expansile cystic lesions in the small bones of the hands have been reported.11 MR imaging of the spine showed patchy high T2-signal-intensity abnormality in the brain stem and throughout the spinal cord without hemorrhage or syringomyelia. Postgadolinium images showed intense enhancement of multiple intra- and extra-medullary lesions (case 1).
Demyelination may occur in some histiocytic disorders. Lesions resembling multiple sclerosis have been described in Erdheim-Chester disease.12,13 In our experience, demyelinating lesions were not seen in patients with xanthoma disseminatum. In the medical literature, the term "xanthoma disseminatum" has been used loosely, and the disease has been confused with other entities. Some case reports of what has been referred to as xanthoma disseminatum of the CNS could fit into other histiocytic disorders, such as Rosai-Dorfman disease. Only a few case reports labeled with this diagnosis were based on modern histochemical techniques. To our knowledge, the disease has never been described in the spinal cord, and our first case is unique in this regard.
Local control of the disease can be achieved with complete surgical excision of the offending tumor. Low-dose radiation therapy (1000 cGy in doses of 200 cGy daily) is known to be beneficial in inflammatory histiocytic disorders, such as Rosai-Dorfman disease. However, it appears that xanthoma disseminatum is radioresistant.14 In some patients with systemic disease, cyclophosphamide was used to control severe symptoms such as stridor, caused by tracheal involvement, and loss of vision, caused by severe periorbital disease, but no recovery of pituitary function was reported after chemotherapy.9,15 We encountered a patient with xanthoma disseminatum who continued to experience local recurrence that progressed to involve the entire neural axis, despite multiple attempts at complete surgical excision and radiation therapy (case 1).
|
References
|
|---|
- Altman J, Winkelmann RK. Diffuse normolipemic plane xanthoma: generalized xanthelasma. Arch Dermatol 1962;85:633–40[Abstract/Free Full Text]
- Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol 1985;13:383–404[Medline]
- Caputo R, Veraldi S, Grimalt R, et al. The various clinical patterns of xanthoma disseminatum: considerations on seven cases and review of the literature. Dermatology 1995;190:19–24[Medline]
- Beurey J, Lamaze B, Weber M, et al. Xanthoma disseminatum (Montgomery’s syndrome). Ann Dermatol Venereol 1963;85:164–70
- Knobler RM, Neumann RA, Gebhart W, et al. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems. J Am Acad Dermatol 1990;23:341–46[Medline]
- Hammond RR, Mackenzie IR. Xanthoma disseminatum with massive intracranial involvement. Clin Neuropathol 1995;14:314–21[Medline]
- Flach DB, Winkelmann RK. Juvenile xanthogranuloma with central nervous system lesions. J Am Acad Dermatol 1986;14:405–11[Medline]
- Giller RH, Folberg R, Keech RV, et al. Xanthoma disseminatum: an unusual histiocytosis syndrome. Am J Pediatr Hematol Oncol 1988;10:252–57[Medline]
- Ray S, Belchetz PE. Xanthoma disseminatum: a rare cause of hypopituitarism. Abstract presented at the British Endocrine Societies, 21st Joint Meeting, Harrogate, United Kingdom, April 8–11, 2002
- Chepuri NB, Challa VR. Xanthoma disseminatum: a rare intracranial mass. AJNR Am J Neuroradiol 2003;24:105–08[Abstract/Free Full Text]
- Blobstein SH, Caldwell D, Carter M. Bone lesions in xanthoma disseminatum. Arch Dermatol 1985;121:1313–17[Abstract/Free Full Text]
- Pfeiffer G, Hagel C, Eckert B, et al. Cerebrocutaneous xanthoma disseminatum and disseminated demyelinating encephalomyelitis. Eur Neurology 2000;44:123–24[Medline]
- Wright RA, Hermann RC, Parisi JE. Neurological manifestations of Erdheim-Chester disease. J Neurol Neurosurg Psychiatry 1999;66:72–75[Abstract/Free Full Text]
- Petzold A, Thom M, Powell M, et al. Relapsing intracranial Rosai-Dorfman disease. J Neurol Neurosurg Psychiatry 2001;71:538–41[Abstract/Free Full Text]
- Seaton ED, Pillai GJ, Chu AC. Treatment of xanthoma disseminatum with cyclophosphamide. Br J Dermatol 2004;150:346–49[Medline]
Received March 22, 2005;
accepted after revision June 3, 2005.
TOP
Abstract
Introduction